The firm recently represented Switzerland-based Lonza Group AG in its roughly $2.3 billion rights offering. The proceeds will be used to finance a portion of the purchase price of Lonza’s previously announced acquisition of Capsugel S.A., a leading maker of capsules and other dosage forms used for the delivery of drugs and food supplements. The rights offering has been fully underwritten by a banking syndicate led by UBS AG and BofA Merrill Lynch acting as Joint Global Coordinators and Joint Bookrunners. Citigroup, Credit Suisse, Goldman Sachs International and J.P. Morgan acted as Joint Bookrunners.
The firm acted as international securities counsel for Lonza Group in this equity offering. The cross-disciplinary team representing Lonza included Partners Kevin T. Collins, Jeffrey R. Shuman, Martin C. Glass, Jared S. Manes, Geoffrey M. Davis, Steven M. Siros and Lee K. Van Voorhis and Associates Rafi W. Mottahedeh, Mark A. Reinhardt and Wei Xu.